1. Home
  2. KE vs TRML Comparison

KE vs TRML Comparison

Compare KE & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KE
  • TRML
  • Stock Information
  • Founded
  • KE 1961
  • TRML 2021
  • Country
  • KE United States
  • TRML United States
  • Employees
  • KE N/A
  • TRML N/A
  • Industry
  • KE Electrical Products
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • KE Technology
  • TRML Health Care
  • Exchange
  • KE Nasdaq
  • TRML Nasdaq
  • Market Cap
  • KE 495.6M
  • TRML 419.1M
  • IPO Year
  • KE N/A
  • TRML N/A
  • Fundamental
  • Price
  • KE $19.74
  • TRML $24.44
  • Analyst Decision
  • KE Buy
  • TRML Strong Buy
  • Analyst Count
  • KE 5
  • TRML 3
  • Target Price
  • KE $22.60
  • TRML $65.00
  • AVG Volume (30 Days)
  • KE 115.8K
  • TRML 214.5K
  • Earning Date
  • KE 02-03-2025
  • TRML 11-07-2024
  • Dividend Yield
  • KE N/A
  • TRML N/A
  • EPS Growth
  • KE N/A
  • TRML N/A
  • EPS
  • KE 0.50
  • TRML N/A
  • Revenue
  • KE $1,650,685,000.00
  • TRML N/A
  • Revenue This Year
  • KE N/A
  • TRML N/A
  • Revenue Next Year
  • KE $4.18
  • TRML N/A
  • P/E Ratio
  • KE $39.56
  • TRML N/A
  • Revenue Growth
  • KE N/A
  • TRML N/A
  • 52 Week Low
  • KE $16.64
  • TRML $12.12
  • 52 Week High
  • KE $27.73
  • TRML $48.31
  • Technical
  • Relative Strength Index (RSI)
  • KE 54.39
  • TRML 45.58
  • Support Level
  • KE $19.28
  • TRML $23.02
  • Resistance Level
  • KE $20.47
  • TRML $26.78
  • Average True Range (ATR)
  • KE 0.59
  • TRML 1.54
  • MACD
  • KE -0.02
  • TRML -0.01
  • Stochastic Oscillator
  • KE 60.80
  • TRML 42.08

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it derives a majority of revenue from the United States.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: